Gvoke VialDx is a concentrated liquid glucagon product. For diagnostic procedures, it works as a gastrointestinal motility inhibitor. The product is supplied as a single-dose vial containing 1mg of ...

Xeris Biopharma (XERS) witnessed a jump in share price last session on above-average trading volume. The latest trend in ...

We recently published a list of 12 Best Stocks to Invest in for a Stock Market Game. In this article, we are going to take a ...

Xeris Biopharma Holdings has received regulatory approval for a new use of its Gvoke liquid glucagon in gastrointestinal ...

Holdings announced that its supplemental new drug application, sNDA, of Gvoke VialDx has received U.S Food and Drug ...

Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patient ...

Robert “Robin” Wilkin, 66, was thrown off the Sliabh Liag/Slieve League cliffs on June 25 2023. Alan Vial, 39, of Drumanoo Head in Killybegs, and Nikita Burns, 24, from An Charraig in Co Donegal, were ...

Maintaining optimal health and wellness is more important than ever in today’s fast-paced world. As individuals become increasingly aware of the impact of lifestyle choices on their overall well-being ...

Source: Xeris Biopharma Holdings, Inc. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This increase was due to increased product revenue ($4.9 million) and additional inventory reserves from process changes required for Gvoke capacity expansion ($4.5 million), offset by lower ...

Nick Blackmer is a librarian, fact-checker, and researcher with more than 20 years of experience in consumer-facing health and wellness content. Eli Lilly has reduced the prices of certain ...